A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

^aDepartment of Electrical Engineering and Computer Science, University of California, Irvine, CA 92697;
^bStanford Genome Technology Center, Stanford University, Stanford, CA 94304;
^cDepartment of Biochemistry, School of Medicine, Stanford University, Stanford, CA 94304

Contributed by R. W. Davis, March 26, 2019 (sent for review February 5, 2019; reviewed by Javad Gatabi and David R. Hillyard)

Footnotes

↵¹To whom correspondence may be addressed. Email: rahimes{at}uci.edu or krhong{at}stanford.edu.

Author contributions: R.E. and R.W.D. designed research; R.E. and J.W. performed research; R.E. and J.W. contributed new reagents/analytic tools; R.E., A.K., and R.W.D. analyzed data; R.E., A.K., M.N.-G., J.W., and R.W.D. wrote the paper; and A.K. helped run experiments.
Reviewers: J.G., R-Water LLC; and D.R.H., University of Utah School of Medicine.
Conflict of interest statement: R.W.D. is Director of the Scientific Advisory Board of the Open Medicine Foundation.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1901274116/-/DCSupplemental.